Compare Roivant Sciences Ltd. Common Shares (ROIV) vs Tripadvisor Inc Common Stock (TRIP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roivant Sciences Ltd. Common Shares vs Tripadvisor Inc Common Stock — how do they compare? Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B), while Tripadvisor Inc Common Stock trades at $8.71 (market cap $1.01B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 24.5× Tripadvisor Inc Common Stock's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, Tripadvisor Inc Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 1 Days and Tripadvisor Inc Common Stock for 57 Days on average.
| ROIV | TRIP | |
|---|---|---|
Market Cap | $24.72B | $1.01B |
Volume | 6,279,442 | 3,004,748 |
Sector | Health | Consumer Cyclical |
52-Week High | $41.81 | $16.72 |
52-Week Low | $16.04 | $8.04 |
Typical Hold Time | 1 Days | 57 Days |
Enterprise Value | $20.99B | $1.06B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TripAdvisor (TRIP) trades at $8.69, up 0.7% on the day, but remains near its 52-week low of $8.27 (Defense World, 2026-09-25). The stock exhibits a mixed technical picture with a bullish overall signal but bearish moving averages. Fundamentally, the company reported Q2 2026 earnings of $0.35 per share, missing the $0.375 estimate (Zacks Investment Research, 2026-08-06), while revenue trends show modest growth from $1.5B in 2022 to $1.9B in 2025. Analyst sentiment is cautious with a consensus price target of $13.58, implying significant upside potential from current levels.
The outlook for TRIP hinges on its ability to stabilize core business performance amid competitive pressures from AI-driven travel platforms. Investment opportunity lies in the discounted valuation relative to analyst targets, but risks include persistent earnings misses, declining net cash flow, and market share erosion. The completion of TheFork subsidiary sale could provide a near-term catalyst, but execution remains key for shareholder value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →About Tripadvisor Inc Common Stock
TripAdvisor is the world's leading travel metasearch company. The website offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2021, 74% of revenue came from the company's core segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 20% of sales in 2021, and TheFork, its dining brand, represented 9% of revenue (about 3% of sales were intersegment, which are eliminated from consolidated revenue).
Read more on TRIP →
